Lipohypertrophy
What the FDA labels record as adverse events, each one tied back to the evidence it came from.
What is Lipohypertrophy?
Thickened, swollen fat at a site injected over and over.
The damaged tissue absorbs the drug erratically, so appetite suppression and results become unpredictable — people often read that as the drug failing. Rotate at least two inches between doses, cycling abdomen, thigh and upper arm across about eight weeks.
Injection-site rotation cheat sheet →
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Lipohypertrophy comes up on this site
On GLP Watchdog, Lipohypertrophy comes up in 1 research article.
Research that discusses it
Other terms under Side effects
Where the evidence lives
- Injection-site rotation cheat sheet
- The full GLP-1 glossary (149 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers